|
End-of-day quote
Xetra
2026-09-17
|
5-day change | 1st Jan Change | ||
| 388.80 EUR | -0.66% |
|
+3.96% | +6.93% |
| 09-13 | Roche Outlines Positive Phase 3 Trial Data for Small-cell Lung Cancer Treatment in China | MT |
| 09-11 | Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11) | RE |
| Market Cap | 285B 347B 302B 259B 485B 33,261B 487B 3,409B 1,317B 16,914B 1,303B 1,274B 54,413B | P/E 2026 * |
19.3x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 296B 360B 313B 269B 503B 34,528B 506B 3,539B 1,367B 17,559B 1,353B 1,323B 56,485B | EV / Sales 2026 * |
4.72x | EV / Sales 2027 * | 4.42x |
| Free-Float |
88.78% | Yield 2026 * |
2.81% | Yield 2027 * | 2.87% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| RO | Delayed | |
CBOE
| 0QQ6 | Real-time | |
|
London S.E.
| 0QQ6 | Delayed | |
|
Tradegate
| RHO | Real-time | |
|
Xetra
| RHO | Delayed | |
|
Xetra
| RHO | End-of-day quote | |
|
Deutsche Boerse AG
| RHO | Delayed | |
|
Börse Stuttgart
| RHO | Delayed | |
|
Boerse Muenchen
| RHO | Real-time | |
|
Borsa Italiana
| 1RO | End-of-day quote | |
|
OTC Markets
| RHHBF | Delayed | |
|
Wiener Boerse
| ROGH | End-of-day quote |
Last Transcript: Roche Holding AG
| 1 day | -0.66% | ||
| 1 week | +3.96% | ||
| Current month | +1.83% | ||
| 1 month | +0.88% | ||
| 3 months | +7.46% | ||
| 6 months | +5.59% | ||
| Current year | +6.93% |
| 1 week | 384.2 |  | 395.6 |
| 1 month | 372.4 | | 407.6 |
| Current year | 333 | | 420.8 |
| 1 year | 283.4 | | 420.8 |
| 3 years | 272.6 | | 420.8 |
| 5 years | 272.6 | | 420.8 |
| 10 years | 181.5 | | 420.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.66% | +3.96% | - | - | 350B | |
| +0.04% | +2.67% | +51.68% | +100.28% | 1,027B | |
| -0.09% | +1.37% | +52.36% | +67.23% | 651B | |
| -0.02% | +3.51% | +19.54% | +73.52% | 467B | |
| -1.22% | +3.27% | +37.02% | +36.52% | 350B | |
| -0.79% | +2.64% | +19.18% | +24.76% | 268B | |
| +0.58% | +6.31% | +9.69% | +14.26% | 257B | |
| +1.55% | +0.83% | +40.38% | +47.92% | 205B | |
| +0.79% | -1.66% | -23.80% | -57.76% | 190B | |
| -0.52% | +3.66% | +33.72% | +98.37% | 187B | |
| Average | -0.02% | +2.49% | +26.64% | +45.01% | 400.23B | |
| Weighted average by Cap. | -0.07% | +2.62% | +35.25% | +61.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.66B 76.18B 66.34B 56.87B 107B 7,309B 107B 749B 289B 3,717B 286B 280B 11,957B | 65.47B 79.61B 69.32B 59.42B 111B 7,637B 112B 783B 302B 3,884B 299B 293B 12,494B |
| Net income | 14.84B 18.04B 15.71B 13.47B 25.24B 1,731B 25.35B 177B 68.54B 880B 67.82B 66.31B 2,832B | 16.44B 19.99B 17.4B 14.92B 27.96B 1,918B 28.08B 197B 75.93B 975B 75.14B 73.47B 3,137B |
| Net Debt | 10.86B 13.2B 11.5B 9.86B 18.47B 1,267B 18.55B 130B 50.16B 644B 49.64B 48.53B 2,072B | 3.99B 4.86B 4.23B 3.63B 6.79B 466B 6.82B 47.77B 18.45B 237B 18.26B 17.85B 762B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | €386.40 | -0.62% | 189 |
| 26-09-17 | €388.80 | -0.66% | 177 |
| 26-09-16 | €391.40 | +0.98% | 221 |
| 26-09-15 | €387.60 | -0.82% | 165 |
| 26-09-14 | €390.80 | +4.72% | 489 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- RHO Stock
Select your edition
All financial news and data tailored to specific country editions
